PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Global cancer statistics PART 06: Reimbursement and coverage: An overview • Current scenario: Validating diagnostic tests • Reimbursement structure in US • Reimbursement structure in EU • Prevailing issues of reimbursement policies PART 07: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 08: Market segmentation by technology • Global tissue diagnostics market by advanced staining • Global tissue diagnostics market by digital pathology • Global tissue diagnostics market by preanalytical and routine staining PART 09: Market segmentation by product • Global tissue diagnostics market segmentation by consumables • Global tissue diagnostics market segmentation by instruments PART 10: Market segmentation by disease • Breast cancer • Lung cancer • Colorectal cancer • Lymphoma • Cervical cancer • Prostate cancer • Other diseases PART 11: Market segmentation by end-user • Hospitals • CROs • Academia and research institutes PART 12: Geographical segmentation • Tissue diagnostics market in Americas • Tissue diagnostics market in EMEA • Tissue diagnostics market in APAC PART 13: Market drivers • Prevalence of chronic diseases • Implementation by new consumers • Use of biomarkers for disease diagnosis • Demand for personalized medicine PART 14: Impact of drivers PART 15: Market challenges • Insurance coverage and reimbursement issues • Limitations of closed systems • High initial investment and maintenance costs PART 16: Impact of drivers and challenges PART 17: Market trends • Ready-to-use reagents • Focus on system automation • Increase in M&A PART 18: Vendor landscape • Competitive scenario • Market share analysis 2015 PART 19: Appendix • List of abbreviations PART 20: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Prevalent cancer types worldwide 2012 Exhibit 03: Countries with highest cancer rate 2012 Exhibit 04: Cancer statistics by gender 2012 Exhibit 05: Reimbursement perspectives of healthcare entities Exhibit 06: Global tissue diagnostics market 2015-2020 ($ billions) Exhibit 07: Five forces analysis Exhibit 08: Global tissue diagnostics market segmentation by technology Exhibit 09: Global tissue diagnostics market segmentation by technology 2015 Exhibit 10: Global tissue diagnostics market segmentation by technology 2020 Exhibit 11: Global tissue diagnostics market segmentation by technology 2015-2020 Exhibit 12: Global tissue diagnostics market segmentation by advanced staining 2015 Exhibit 13: Global tissue diagnostics market segmentation by advanced staining 2020 Exhibit 14: Global tissue diagnostics market segmentation by advanced staining 2015-2020 Exhibit 15: Global tissue diagnostics market by IHC 2015-2020 ($ billions) Exhibit 16: Global tissue diagnostics market by ISH 2015-2020 ($ millions) Exhibit 17: Types of ISH Exhibit 18: Comparative analysis of CISH, FISH, and IHC Exhibit 19: Global tissue diagnostics market by advanced staining 2015-2020 ($ billions) Exhibit 20: Geographical segmentation of global tissue diagnostics market by advanced staining 2015 Exhibit 21: Global tissue diagnostics market by digital pathology 2015-2020 ($ billions) Exhibit 22: Geographical segmentation of global tissue diagnostics market by digital pathology 2015 Exhibit 23: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015 Exhibit 24: Global tissue diagnostics market segmentation by preanalytical and routine staining 2020 Exhibit 25: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015-2020 Exhibit 26: Global tissue diagnostics market by preanalytical staining 2015-2020 ($ millions) Exhibit 27: Global tissue diagnostics market by H&E staining 2015-2020 ($ millions) Exhibit 28: Common special stains used for histological studies Exhibit 29: Global tissue diagnostics market by special staining 2015-2020 ($ millions) Exhibit 30: Global tissue diagnostics market by preanalytical and routine staining 2015-2020 ($ billions) Exhibit 31: Geographical segmentation of global tissue diagnostics market by preanalytical and routine staining 2015 Exhibit 32: Global tissue diagnostics market segmentation by product Exhibit 33: Global tissue diagnostics market segmentation by product 2015 Exhibit 34: Global tissue diagnostics market segmentation by product 2020 Exhibit 35: Global tissue diagnostics market segmentation by product 2015-2020 Exhibit 36: Global tissue diagnostics market by consumables 2015-2020 ($ billions) Exhibit 37: Global tissue diagnostics market by instruments 2015-2020 ($ billions) Exhibit 38: Global tissue diagnostics market segmentation by disease Exhibit 39: Global tissue diagnostics market segmentation by disease type 2015 Exhibit 40: Global tissue diagnostics market segmentation by end-user Exhibit 41: Global tissue diagnostics market segmentation by end-user 2015 Exhibit 42: Global tissue diagnostics market segmentation by geography 2015 Exhibit 43: Global tissue diagnostics market segmentation by geography 2020 Exhibit 44: Global tissue diagnostics market segmentation by geography 2015-2020 Exhibit 45: Tissue diagnostics market in Americas 2015-2020 ($ billions) Exhibit 46: Segmentation of tissue diagnostics market in Americas by technology 2015 Exhibit 47: Tissue diagnostics market in EMEA 2015-2020 ($ billions) Exhibit 48: Segmentation of tissue diagnostics market in EMEA by technology 2015 Exhibit 49: Tissue diagnostics market in APAC 2015-2020 ($ millions) Exhibit 50: Segmentation of tissue diagnostics market in APAC by technology 2015 Exhibit 51: Impact of drivers Exhibit 52: Impact of drivers and challenges Exhibit 53: Ranking of top vendors 2015 Exhibit 54: Roche Diagnostics: Key takeaways Exhibit 55: Agilent Technologies: Key takeaways Exhibit 56: Danaher: Key takeaways Exhibit 57: Abbott Diagnostics: Key takeaways

Abbott Diagnostics, Agilent Technologies (a parent company of Dako), Danaher (a parent company of Leica Biosystems), Roche Diagnostics, 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Affymetrix, Agendia, AutoGenomics, AVIVA BioSciences, Biocare Medical, Biocartis, Cancer Genetics, ELITechGroup, Enzo Biochem, Epic Sciences, Fluidigm, HORIBA Medical, Janssen Diagnostics, Olympus Diagnostics Systems Group, Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US), Oxford Gene Technology, PANAGENE, Protea Biosciences Group, Sakura Finetek